Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) (“Eagle” or the “Company”) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the Piper Jaffray 26th Annual Healthcare Conference as follows:
|
Date: |
Wednesday, December 3, 2014 |
|||
|
Time: |
2:00 p.m. EST |
|||
|
Location: |
The New York Palace Hotel in New York City |
|||
The presentation will be webcast live at the aforementioned time and simultaneously available via the link provided, as well as archived for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. The Company’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.
In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President